Amylin fibrillation is proposed to parallel other amyloidosis, such as amyloid-β in dementia, in driving pancreatic β-cell apoptosis and may therefore be an important treatment target in T1DM [13], including in relation to the ‘autoimmune’ aspects of T1DM. This evidence concerns the gene IAPP and type 1 diabetes mellitus.